Back

Right ventricular systolic pressure is an independent risk factor of all-cause death and inappropriate therapies in patients with implanted CRT-D

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Cardiac resynchronisation therapy - conduction system pacing 1 Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Joanna Machowicz

Silesian Center for Heart Diseases (SCHD), Zabrze (Poland)

7 More presentations in this session

Presentation thumbnail
Electrocardiographic predictors of haemodynamic benefit from biventricular pacing: the role of atrioventricular timing measures
Doctor T. Chakraborty (London, GB) Doctor A. Arnold (London, GB)
Abstract Slides Video
Presentation thumbnail
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial.
Doctor J. Francisco Pascual (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
His bundle pacing implantation in octogenarian patients: a substudy of the PACE-CONDUCT trial
Doctor D. Stangl (Fuerth, DE)
Abstract Slides Video
Presentation thumbnail
Temporal evolution of His bundle pacing thresholds: a sub-study of the PACE-CONDUCT trial
Doctor V. Buia (Fuerth, DE)
Abstract Slides Video
Presentation thumbnail
A time-dependent analysis of sacubitril/valsartan and gliflozins benefits in patients receiving cardiac resynchronization therapy
Doctor D. Faccenda (Lugan, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac resynchronisation therapy - conduction system pacing 1

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Impact of right ventricular dimension and function on outcomes in patients undergoing cardiac resynchronization therapy
thumbnail
Congress Presentation
Identifying predictors of non-response to cardiac resynchronization therapy in heart failure patients
thumbnail
Congress Presentation
Predictors of future need for cardiac resynchronization therapy (CRT) in HFrEF.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources